EBITEHAL ELBESHIR: Open Payments
NPI 1275901704 · DEARBORN HEIGHTS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$267 in 12 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $125 · 2025 $267
Food & beverage: $267
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $81 |
| ABBVIE INC. | 2 | $61 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Antares Pharma, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $14 |
Products named: VRAYLAR, CREON, VERQUVO, CAPLYTA, XYOSTED, NURTEC ODT, REXULTI, BREZTRI.
Industry payments across MI — which companies pay providers there.
